Rob Galioto

Rob Galioto has extensive experience in data strategy and analytics. Rob is currently the Director of Data Strategy & Analytics at US Pharmacopeia, where they lead enterprise data strategy initiatives and manages data analytics teams. Rob is responsible for building data capabilities and products to support digital and innovation initiatives. Prior to this role, Rob served as the Interim Director of Data Strategy & Analytics at US Pharmacopeia.

Before joining US Pharmacopeia, Rob worked at ATCC as a Marketing Analyst, where they focused on data analytics to support decision-making in product line management, sales, and marketing. Rob also supported the sales force through reporting and opportunity mining.

Earlier in their career, Rob was the Principal at Leverage Analytics, LLC, where they gained experience in various analytics projects. Rob also served as the Director of Business Development at Integrated BioTherapeutics, Inc. and IBT Bioservices, where they led business development efforts and introduced data-based decision practices.

Rob's career started at UB STOR, where they worked as a Marketing Assistant, conducting market analysis assessments for new biotech inventions. Rob then moved on to United Biochemicals as a Product Manager, responsible for OEM accounts and improving costing and pricing models.

Overall, Rob Galioto has a strong background in data strategy, analytics, and business development, with a focus on leveraging data to drive value and support decision-making in various industries.

Rob Galioto has an MBA in Marketing and Biotech Management from the University at Buffalo School of Management, The State University of New York. Prior to that, they obtained a Bachelor of Science degree in Biology from SUNY Geneseo. Additionally, they have several certifications including Artificial Intelligence and Business Strategy, Introducing AI to Your Organization, Oracle BI 11g R1: Create Analyses and Dashboards, The Data Scientist’s Toolbox, and IBM Cognos Report Studio: Author Professional Reports.